Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.190
-0.020 (-0.90%)
Mar 25, 2026, 12:01 PM EDT - Market open
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $50.9 million as of March 25, 2026. Its market cap has decreased by -64.20% in one year.
Market Cap
50.90M
Enterprise Value
34.44M
1-Year Change
-64.20%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $50.90M, a decrease of -66.54%. That is a compound annual growth rate of -49.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 51.37M | -63.89% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 54.42M |
| Lipocine | 53.73M |
| Mereo BioPharma Group | 53.63M |
| Immutep | 52.99M |
| Metagenomi Therapeutics | 51.54M |
| Radiopharm Theranostics | 48.91M |
| OS Therapies | 48.60M |
| Xilio Therapeutics | 48.40M |